Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field

By Da Villa G.   Picciottoc L.   Elia S.   Peluso F.   Montanaro F.   Maisto T.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1240-1243

Elsevier

Access to resources Recommend Favorite

The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns

By Lee S.S.   Young B.W.Y.   Wong K.H.   Lim W.L.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3752-3754

Elsevier

Access to resources Recommend Favorite

Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France

By Levy-Bruhl D.   Desenclos J.-C.   Rebiere I.   Drucker J.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2065-2071

Elsevier

Access to resources Recommend Favorite

An effective intradermal hepatitis B vaccination

By Yamashiki M.   Kosaka Y.   Nishimura A.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1618-1623

Elsevier

Access to resources Recommend Favorite

A reduced dose approach to hepatitis B vaccination for low-risk newborns and preschool children

By Lee S.S.   Lo Y.C.   Young B.W.Y.   Wong K.H.   Lim W.L.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 373-376

Elsevier

Access to resources Recommend Favorite